Source: BioPortfolio

Baxalta: Baxalta Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10032017 Prices from USD $250

SummaryBaxalta Inc Baxalta is a biopharmaceutical company that develops manufactures and commercializes therapies for orphan diseases. The company offers products for the treatment of orphan diseases related to cancer and hematological and immunological di...

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more